of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort Br Med J.2009;339:b4606 Report from the CCSS cohort that established rates of CTC in survivors of pediatric cancer for several decades after treatment and serves as the basis of several subsequent studies Plana JC, Galderisi M, Barac A, et al Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American society of echocardiography and the European association of cardiovascular imaging J Am Soc Echocardiogr.2014;27(9):911–939 American Society of Echocardiography recommendations for following adult patients during and after cancer therapy, with use of imaging and serum biomarkers Shaikh F, Dupuis LL, Alexander S, Gupta A, Mertens L, Nathan PC Cardioprotection and second malignant neoplasms associated with dexrazoxane in children receiving anthracycline chemotherapy: a systematic review and metaanalysis J Natl Cancer Inst.2016;108(4) Meta-analysis concluding that the balance of risk for CTC versus secondary malignant neoplasms should be considered in making the decision of whether to use dexrazoxane in pediatric cancer populations Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review J Am Coll Cardiol.2014;63(25 Pt A):2751–2768 Comprehensive review of myocardial strain imaging (echocardiography) in patients for the early detection of CTC Included are reviews of several pediatric studies van Dalen EC, van der Pal HJ, Kremer LC Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy Cochrane Database Syst Reviews.2016;(3) [CD005008] Systematic review of variable dosing schedules and alternate anthracycline formulations in preventing CTC Longer infusion time and liposomal-encapsulated doxorubicin were found protective, however adult populations made up the majority of the studies Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European society of cardiology (ESC) Eur Heart J.2016;37(36):2768–2801 Detailed and specific guidelines for management of CTC in adult patients, produced by the European Society of Cardiology ... European society of cardiology (ESC) Eur Heart J.2016;37(36):2768–2801 Detailed and specific guidelines for management of CTC in adult patients, produced by the European Society of Cardiology ... imaging (echocardiography) in patients for the early detection of CTC Included are reviews of several pediatric studies van Dalen EC, van der Pal HJ, Kremer LC Different dosage schedules for reducing...should be considered in making the decision of whether to use dexrazoxane in pediatric cancer populations Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH Use of myocardial strain